U.S. Bioscience news

The proposed settlement includes $10 million in UBS units and $5.3 million in cash to be contributed by three insurance companies that provide liability insurance to the company.

The units will consist of one share of common stock and warrants to buy one share of common at a price 30 percent higher than the average trading price over a 10-day trading period immediately preceding the date that court approval of the settlement becomes final and non-appealable. The warrants would be exercisable for three years. ...